Issue 2/2013
Content (34 Articles)
Clinicopathological significance of KU70/KU80, a key DNA damage repair protein in breast cancer
Alaa T. Alshareeda, Ola H. Negm, Nada Albarakati, Andrew R. Green, Christopher Nolan, Rebeka Sultana, Srinivasan Madhusudan, Ahmed benHasouna, Paddy Tighe, Ian O. Ellis, Emad A. Rakha
Micro-computed tomography (Micro-CT): a novel approach for intraoperative breast cancer specimen imaging
Rong Tang, Julliette M. Buckley, Leopoldo Fernandez, Suzanne Coopey, Owen Aftreth, James Michaelson, Mansi Saksena, Lan Lei, Michelle Specht, Michele Gadd, Yukako Yagi, Elizabeth Rafferty, Elena Brachtel, Barbara L. Smith
Platform comparisons for identification of breast cancers with a BRCA-like copy number profile
Philip C. Schouten, Ewald van Dyk, Linde M. Braaf, Lennart Mulder, Esther H. Lips, Jorma J. de Ronde, Laura Holtman, Jelle Wesseling, Michael Hauptmann, Lodewyk F. A. Wessels, Sabine C. Linn, Petra M. Nederlof
The impact of cyclin D1 overexpression on the prognosis of ER-positive breast cancers: a meta-analysis
Xiao-Ling Xu, Shu-Zheng Chen, Wei Chen, Wei-Hui Zheng, Xiang-Hou Xia, Hong-Jian Yang, Bo Li, Wei-Min Mao
DNA promoter hypermethylation profiles in breast duct fluid
Dominique Twelves, Ashutosh Nerurkar, Peter Osin, Tim Dexter, Ann Ward, Gerald P. H. Gui, Clare M. Isacke
Fulvestrant regulates epidermal growth factor (EGF) family ligands to activate EGF receptor (EGFR) signaling in breast cancer cells
Xihong Zhang, Michael R. Diaz, Douglas Yee
Rank-based predictors for response and prognosis of neoadjuvant taxane-anthracycline-based chemotherapy in breast cancer
Lin Zhang, Chunxiang Hao, Xiaopei Shen, Guini Hong, Hongdong Li, Xianxiao Zhou, ChunYang Liu, Zheng Guo
Prognostic significance of the tumor-stroma ratio: validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy (POP) trial (10854)
T. J. A. Dekker, C. J. H. van de Velde, G. W. van Pelt, J. R. Kroep, J-P. Julien, V. T. H. B. M. Smit, R. A. E. M. Tollenaar, W. E. Mesker
FOXP3-positive regulatory T lymphocytes and epithelial FOXP3 expression in synchronous normal, ductal carcinoma in situ, and invasive cancer of the breast
Aseem Lal, Loretta Chan, Sandy DeVries, Koei Chin, Gary K. Scott, Christopher C. Benz, Yunn-Yi Chen, Frederic M. Waldman, E. Shelley Hwang
Acute inflammation induced by the biopsy of mouse mammary tumors promotes the development of metastasis
Julia Hobson, Phani Gummadidala, Brian Silverstrim, Dore Grier, Janice Bunn, Ted James, Mercedes Rincon
A phase II study of bevacizumab in combination with vinorelbine and trastuzumab in HER2-positive metastatic breast cancer
N. U. Lin, D. S. Seah, R. Gelman, S. Desantis, E. L. Mayer, S. Isakoff, P. DiPiro, I. E. Krop, S. E. Come, D. Weckstein, E. P. Winer, H. J. Burstein
A randomized, phase II, three-arm study of two schedules of ixabepilone or paclitaxel plus bevacizumab as first-line therapy for metastatic breast cancer
Hope S. Rugo, Mario Campone, Dino Amadori, Daniela Aldrighetti, PierFranco Conte, Andrew Wardley, Cristian Villanueva, Michelle Melisko, M. Brent McHenry, David Liu, Francis Lee, Xavier Pivot
Influence of ABCB1 polymorphisms and docetaxel pharmacokinetics on pathological response to neoadjuvant chemotherapy in breast cancer patients
Pierre Lévy, Joseph Gligorov, Martine Antoine, Keyvan Rezai, Eric Lévy, Frédéric Selle, Pierre Saintigny, François Lokiec, Danielle Avenin, Karine Beerblock, Jean-Pierre Lotz, Jean-François Bernaudin, Anne Fajac
Shared decision-making in metastatic breast cancer: discrepancy between the expected prolongation of life and treatment efficacy between patients and physicians, and influencing factors
Michael P. Lux, Christian M. Bayer, Christian R. Loehberg, Peter A. Fasching, Michael G. Schrauder, Mayada R. Bani, Lothar Häberle, Anne Engel, Katharina Heusinger, Thorsten Tänzer, Dragan Radosavac, Anton Scharl, Ingo Bauerfeind, Judith Gesslein, Hilde Schulte, Brigitte Overbeck-Schulte, Matthias W. Beckmann, Alexander Hein
A randomized, double-blind, controlled study of exemestane versus anastrozole for the first-line treatment of postmenopausal Japanese women with hormone-receptor-positive advanced breast cancer
Hiroji Iwata, Norikazu Masuda, Shinji Ohno, Yoshiaki Rai, Yasuyuki Sato, Shozo Ohsumi, Satoshi Hashigaki, Yoshinori Nishizawa, Masahiro Hiraoka, Tadaoki Morimoto, Hironobu Sasano, Toshiaki Saeki, Shinzaburo Noguchi
Risk factors for non-invasive and invasive local recurrence in patients with ductal carcinoma in situ
Laura C. Collins, Ninah Achacoso, Reina Haque, Larissa Nekhlyudov, Suzanne W. Fletcher, Charles P. Quesenberry Jr., Stuart J. Schnitt, Laurel A. Habel
Adiponectin pathway polymorphisms and risk of breast cancer in African Americans and Hispanics in the Women’s Health Initiative
Virginia G. Kaklamani, Thomas J. Hoffmann, Timothy A. Thornton, Geoffrey Hayes, Rowan Chlebowski, Linda Van Horn, Christos Mantzoros
Comorbidity and outcomes after surgery among women with breast cancer: analysis of nationwide in-patient sample database
Ahmed Dehal, Ali Abbas, Samir Johna
Pretreatment levels of circulating Th1 and Th2 cytokines, and their ratios, are associated with ER-negative and triple negative breast cancers
Chi-Chen Hong, Song Yao, Susan E. McCann, Ree Y. Dolnick, Paul K. Wallace, Zhihong Gong, Lei Quan, Kelvin P. Lee, Sharon S. Evans, Elizabeth A. Repasky, Stephen B. Edge, Christine B. Ambrosone
Time-dependent resource use and costs associated with different states of disease in patients diagnosed with HER-2-positive metastatic breast cancer
G. W. J. Frederix, J. L. Severens, A. M. Hövels, J. G. C. van Hasselt, J. A. M. Raaijmakers, J. H. M. Schellens
Black race as a prognostic factor in triple-negative breast cancer patients treated with breast-conserving therapy: a large, single-institution retrospective analysis
Carmen A. Perez, Zachary S. Zumsteg, Gaorav Gupta, Monica Morrow, Brittany Arnold, Sujata M. Patil, Tiffany A. Traina, Mark E. Robson, Yong H. Wen, Beryl McCormick, Simon N. Powell, Alice Y. Ho
Beta blockers and angiotensin-converting enzyme inhibitors’ purported benefit on breast cancer survival may be explained by aspirin use
Michelle D. Holmes, Susan E. Hankinson, Diane Feskanich, Wendy Y. Chen
Social networks, social support mechanisms, and quality of life after breast cancer diagnosis
Candyce H. Kroenke, Marilyn L. Kwan, Alfred I. Neugut, Isaac J. Ergas, Jaime D. Wright, Bette J. Caan, Dawn Hershman, Lawrence H. Kushi
Postdiagnosis supplement use and breast cancer prognosis in the After Breast Cancer Pooling Project
Elizabeth M. Poole, XiaoOu Shu, Bette J. Caan, Shirley W. Flatt, Michelle D. Holmes, Wei Lu, Marilyn L. Kwan, Sarah J. Nechuta, John P. Pierce, Wendy Y. Chen
Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry
E. C. Inwald, M. Klinkhammer-Schalke, F. Hofstädter, F. Zeman, M. Koller, M. Gerstenhauer, O. Ortmann
Influence of CYP2D6-genotype on tamoxifen efficacy in advanced breast cancer
Jennifer Karle, Juliane Bolbrinker, Silvia Vogl, Reinhold Kreutz, Carsten Denkert, Jan Eucker, Manfred Wischnewsky, Kurt Possinger, Anne C. Regierer
Racial disparities in clinical presentation, surgical treatment and in-hospital outcomes of women with breast cancer: analysis of nationwide inpatient sample database
Ahmed Dehal, Ali Abbas, Samir Johna
Simplifying clinical use of the genetic risk prediction model BRCAPRO
Swati Biswas, Philamer Atienza, Jonathan Chipman, Kevin Hughes, Angelica M. Gutierrez Barrera, Christopher I. Amos, Banu Arun, Giovanni Parmigiani
Patient–physician interaction and quality of life in recently diagnosed breast cancer patients
Marilyn L. Kwan, Emily K. Tam, Isaac J. Ergas, David H. Rehkopf, Janise M. Roh, Marion M. Lee, Carol P. Somkin, Anita L. Stewart, Lawrence H. Kushi
Germline mutations in NF1 and BRCA1 in a family with neurofibromatosis type 1 and early-onset breast cancer
Berta Campos, Judith Balmaña, Josep Gardenyes, Irene Valenzuela, Oscar Abad, Pere Fàbregas, Víctor Volpini, Orland Díez
Evolution of sites of recurrence after early breast cancer over the last 20 years: implications for patient care and future research
N. Bouganim, E. Tsvetkova, M. Clemons, E. Amir
Cognitive function in older women with breast cancer treated with standard chemotherapy and capecitabine on Cancer and Leukemia Group B 49907
Rachel A. Freedman, Brandelyn Pitcher, Nancy L. Keating, Karla V. Ballman, Jeanne Mandelblatt, Alice B. Kornblith, Gretchen G. Kimmick, Arti Hurria, Eric P. Winer, Clifford A. Hudis, Harvey Jay Cohen, Hyman B. Muss
Methodological remarks concerning a recent meta-analysis on XPG Asp1104His and XPF Arg415Gln polymorphisms and breast cancer risk
Qiliu Peng, Xianjun Lao, Ruoling Li, Xue Qin, Shan Li
What is the clinical significance of the volume of tissue excised in ROLL?
Muneer Ahmed, Michael Douek